Today: 19 May 2026
Asus hits pause on smartphones: no new Zenfone or ROG Phone models expected in 2026
20 January 2026
1 min read

Asus hits pause on smartphones: no new Zenfone or ROG Phone models expected in 2026

Taipei, January 20, 2026, 23:38 (GMT+8)

Asus chairman Jonney Shih announced the company will halt the launch of new smartphone models, putting its Zenfone and ROG Phone lines in question. Speaking to Taiwan’s Inside, Shih said Asus “will no longer add new mobile phone models in the future” and plans to enter a phase of “indefinite observation,” though it will “continue to take care of the brand’s mobile phone users.” The company has already slowed down releases, with just two models planned for 2025—none of which are headed to the U.S., according to The Verge.

Asus is shifting gears, reallocating engineers and budget from phones to areas it sees as growth drivers. The company plans to pivot smartphone R&D toward commercial PCs and “physical AI devices” like robots and smart glasses, according to 9to5Google. 9to5Google

“Physical AI” refers to AI embedded in hardware that interacts with the real world, not just software in apps or the cloud. For Asus, this highlights a gap in its Android phone lineup—and an even larger one for its gaming-centric ROG brand, short for Republic of Gamers.

Engadget reported that translations of Shih’s remarks indicate the company isn’t merely missing one product cycle but intends to halt new phone model releases altogether.

Ars Technica reported that Asus’s smartphone division is on an “indefinite hiatus,” warning that no new Zenfone or ROG Phone models are expected in 2026. Ars Technica

Asus occupies a smaller slice of the Android market, which is largely ruled by Apple and Samsung. Its gaming phones go head-to-head with rivals like ZTE’s Nubia RedMagic series.

Germany’s Heise offered a different take on the shift, reporting that Shih described it as a reaction to a “paradigm shift” fueled by AI. He also pointed to memory supply constraints that might raise prices on some products beyond the AI-focused range. heise online

The company gained a loyal following with its Zenfone handsets, then boosted it further with ROG Phone devices packed with gaming features, big batteries, and performance-driven designs. Now, those users are stuck waiting longer for fresh hardware to hit the market.

Asus hasn’t clarified what “take care” actually involves. Timelines for software updates, availability of repair parts, and warranty services could all become unpredictable if the pause extends and teams start to break up.

Asus hasn’t set a schedule for resuming phone development. Its chairman described the decision as a wait-and-see approach. For the moment, the company is banking on growth coming from PCs and AI hardware rather than launching another flagship phone.

Stock Market Today

  • Wall Street Falls on Rising Oil Prices, Iran Concerns; Dow Drops 1.1%
    May 19, 2026, 6:07 AM EDT. Wall Street closed lower on May 18 as rising oil prices surged 3.4% to $109 a barrel and geopolitical tensions with Iran increased. The Dow Jones Industrial Average fell 1.1% to 49,526.17, led by a 4.4% drop in NVIDIA shares. The tech-heavy Nasdaq declined 1.5%, while the S&P 500 lost 1.2%. Defensive sectors like Energy rose as others, including Materials and Utilities, fell. The CBOE Volatility Index jumped 6.8%, signaling increased market fear. Industrial production surprised with a 0.7% April gain, and the NY Empire State Manufacturing Index surged to 19.6, pointing to robust manufacturing activity despite global tensions.

Latest articles

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.
Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

19 May 2026
Alphabet shares rose in pre-market trading Tuesday after Google and Blackstone announced a U.S. AI cloud venture, with Blackstone committing $5 billion to add 500 megawatts of data-center capacity by 2027. Alphabet’s Class A shares closed Monday at $396.94 and were quoted at $401.09 before the market opened. The move coincides with the first day of Google I/O and follows strong Q1 earnings.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Amazon’s AWS European Sovereign Cloud Is Powering New “Forever Portfolio” Stock Picks — Here’s Who Else Made the Cut
Previous Story

Amazon’s AWS European Sovereign Cloud Is Powering New “Forever Portfolio” Stock Picks — Here’s Who Else Made the Cut

Tesla stock slides with Wall Street on tariff jitters as Canada import shift, supply dispute loom
Next Story

Tesla stock slides with Wall Street on tariff jitters as Canada import shift, supply dispute loom

Go toTop